1-6 of 6
Katherine Parker Ponder
Close
Sort by
Journal Articles

An ounce of prevention potentiates a pound of cure for hemophilia A

Katherine Parker Ponder
Journal: Blood
Blood (2005) 105 (7): 2620.
https://doi.org/10.1182/blood-2005-01-0245
Published: 2005
Journal Articles

A more clinically relevant mouse model of hemophilia B

Katherine Parker Ponder
Journal: Blood
Blood (2004) 104 (6): 1595.
https://doi.org/10.1182/blood-2004-06-2397
Published: 2004
Journal Articles

Neonatal gene transfer with a retroviral vector results in tolerance to human factor IX in mice and dogs

Jun Zhang, Lingfei Xu, Mark E. Haskins, Katherine Parker Ponder
Journal: Blood
Blood (2004) 103 (1): 143–151.
https://doi.org/10.1182/blood-2003-06-2181
Published: 2004
Journal Articles

Novel therapies for hemophilia A

Katherine Parker Ponder
Journal: Blood
Blood (2003) 102 (12): 3857–3858.
https://doi.org/10.1182/blood-2003-09-3208
Published: 2003
Journal Articles

Neonatal or hepatocyte growth factor–potentiated adult gene therapy with a retroviral vector results in therapeutic levels of canine factor IX for hemophilia B

Lingfei Xu, Cuihua Gao, Mark S. Sands, Shi-Rong Cai, Timothy C. Nichols, Dwight A. Bellinger, Robin A. Raymer, Stephanie McCorquodale, Katherine Parker Ponder
Journal: Blood
Blood (2003) 101 (10): 3924–3932.
https://doi.org/10.1182/blood-2002-10-3050
Published: 2003
Journal Articles

Therapeutic Levels of Functional Human Factor X in Rats After Retroviral-Mediated Hepatic Gene Therapy

MaiThao Le, Torayuki Okuyama, Shi-Rong Cai, Susan C. Kennedy, William M. Bowling, M. Wayne Flye, Katherine Parker Ponder
Journal: Blood
Blood (1997) 89 (4): 1254–1259.
https://doi.org/10.1182/blood.V89.4.1254
Published: 1997